Drug Index


Mechanism :

Levofloxacin inhibits bacterial type II topoisomerases, topoisomerase IV and DNA gyrase. Levofloxacin, like other fluoroquinolones, inhibits the A subunits of DNA gyrase, two subunits encoded by the gyrA gene. This results in strand breakage on a bacterial chromosome, supercoiling, and resealing; DNA replication and transcription is inhibited.

Indication :

  • Inhalational anthrax
  • Plague
  • Acute bacterial rhinosinusitis (off-label)
  • Community-acquired pneumonia, bacterial (off label)
  • Community-acquired pneumonia, atypical (off label)
  • Multidrug resistant tuberculosis

Contraindications :

Hypersensitivity to drug/class/component

Prolonged QT interval, Hypokalemia, Myasthenia gravis, Colitis history.

Caution if proarrhythmic condition, renal impairment, seizure disorder or seizure threshold lowered, CNS disorder, dehydration, diabetes mellitus.

Caution if kidney, heart or lung transplant.

Dosing :

Use in children above 6 months of age.
Inhalational anthrax, plague:
<50 kg:
16-20 mg/kg/day orally in two divided doses. Max: 750 mg/day.
>50 kg:
500 mg orally once a day. Max: 750 mg/day.
2 months for inhalational anthrax, 10-14 days for plague, 10 days for acute bacterial sinusitis, community acquired bacterial pneumonia, community acquired atypical pneumonia.

Adverse Effect :

Common Reactions: Nausea, headache, diarrhea, insomnia, constipation, dizziness, abdominal pain, vomiting, dyspepsia, tendinitis.

Serious Reactions: Anaphylaxis, hypersensitivity reaction, toxic psychosis, phototoxicity, Clostridium difficile associated diarrhea, depression, superinfection, Raised ICP, seizures, suicidal ideation, QT prolongation, skin reaction, severe torsades de pointes, vasculitis, pneumonitis, hypersensitivity, serum sickness, nephrotoxicity, hepatotoxicity, myelosuppression, blood dyscrasias, peripheral neuropathy, tendon rupture, arthralgia/myalgia, arthropathy (animal studies), myasthenia gravis, exacerbation.

Interaction :

Amiodarone, BCG live intravesical, Cisapride, Disopyramide, Dofetilide, Dronedarone, Ibutilide, Pimozide, Procainamide, Quinidine (Antiarrhythmic), Sotalol, Thioridazine, Ziprasidone.
Avoid/Use Alternative:
Aminolevulinic acid topical, Arsenic Trioxide, Artemether/lumefantrine, Asenapine, Bedaquiline, Ciprofloxacin, Clarithromycin, Crizotinib, Degarelix, Dolasetron, Ephedra, Ephedrine, Erythromycin, Goserelin, Haloperidol, Histrelin, Iloperidone, Leuprolide, Lopinavir/Ritonavir, Methadone, Mifepristone, Nilotinib, Paliperidone, Pasireotide, Pentamidine, Quinine, Ranolazine, Saquinavir, Sunitinib, Telavancin, Tetrabenazine, Toremifene, Triptorelin, Typhoid vaccine live, Vandetanib.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Initial dose 250–500 mg then reduce dose by 50%
10-20Initial dose 250–500 mg then 125 mg 12–24 hourly
<10Initial dose 250–500 mg then 125 mg 24–48 hourly

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in GFR<10 mL/min
HDNot dialysed. Dose as in GFR<10 mL/min
HDF/High fluxNot dialysed. Dose as in GFR<10 mL/min
CAV/VVHDNot dialysed. Loading dose: 500 mg then 250 mg every 24 hours

Hepatic Dose :

No dose adjustments are recommended.
01/23/2024 12:27:02 Levofloxacin
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0